Phase I study of the combination of BKM120 and bevacizumab in patients with relapsed/refractory glioblastoma multiforme (GBM) or other refractory solid tumors.
Kent C. Shih
No relevant relationships to disclose
Peter Acs
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
Lowell L. Hart
No relevant relationships to disclose
Rebecca A. Kosloff
No relevant relationships to disclose
Ruth E. Lamar
No relevant relationships to disclose
John D. Hainsworth
No relevant relationships to disclose